SUMF1 and Multiple sulfatase deficiency: We assumed that increased transcription of sulfatases genes, known interacting partners of FGE, or SUMF1, the only known activating factor for sulfatases, could be an underlying cause for the sulfatase activity increase upon tazarotene and bexarotene treatment in MSD cells.